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Familial Cutaneous Lichen Amyloidosis in Association with Multiple
Endocrine Neoplasia Type 2A: A New Variant
D.T. Donovan,* M.L. Levy,* E.J. Furst,* B.R. Aiford,* T. Wheeler,*, J.A. Tschen,*
and R . E GageP

Multiple endocrine neoplasia type 2 A (MEN 2A) is a rare hereditary disease transmitted in families as
an autosomal dominant trad. We have idenlified a family in which the expression of a rare autosomal
dominant form of cutaneous lichen amyloidosis appears to cosegregate with MEN 2A. In this family
the skin lesion presented as muUiple infiltrated papules overlying well demarcated plaques over the
scapular area (right or left). Immunohistochemical .studies demonstrated amyloid which stained for
keratin bul nol calcitonin. A tcrtal of 19 members were screened. Three members of the family have the
characteristic skin lesion and MEN 2A; two additional members have MEN 2A hul have not manifested
observable skin changes of lichen amyloidosis. Another unrelated Italian family wilh a similar type of
pruritic skin rash and MEN 2A has been reported recenlly. Although the indial skin biopsies were
negalive for amyloidosis, subsequeni biopsy established the associalion of MEN 2 A with amyloidosis
in this family also. When these kindreds are combined, several conclusions can be drawn. First, the
syndrome of cutaneous amyloidosis and MEN 2A appears to be a clearly defined autosomal dominant
hereditary syndrome. Whether this syndrome can he linked lo chromosome 10 is nol yet known.
Second, the dermal amyloid appears lo be caused hy deposition of keratin-like peptides raiher than
calcilonin-like peptides. Third, we believe that patients wdh the hereditary form of cutaneous amyloid
should he screenedfor medullary thyroid carcinoma lo delermine the true frequency ofthis syndrome.
(Henry Ford Hosp MedJ 1989;37:147-50)

M

ultiple endocrine neoplasia type 2A (MEN 2A) is a rare
clinical syndrome of malignant tumors that is transmitted
in an autosomally dominant pattern (1). tt results in medullary
thyroid carcinoma (MTC), pheochromocytoma, and parathyroid hyperplasia. Since its initial description as a clinical entity and its characterization as a genetic syndrome, MEN 2A has
undergone intensive scientific investigation because it is a weltdelineated example of hereditary malignancy (2-4). Early investigative efforts focused on delineation of the clinical characteristics of the syndrome and led to the discovery of calcitonin
(CT) as a tumor marker (5-8). The second evolutionary phase of
the disease has been the introduction and widespread employment of prospective family screening to improve treatment of
the disease (9,10). The third phase has been the application of
modem molecular biologic techniques to search for the genetic
defect responsible for the syndrome. Investigation in recent
years has resulted in mapping of the gene of MEN 2A to chromosome 10(11-13).
Hereditary lichen amyloidosis is a rare skin disease transmitted as an autosomally dominant trait that presents as a scaly,
papular lesion associated with intense praritus. It may occur on
the back or extensor surfaces of the extremities. During roufine
screening of a recently discovered family with MEN 2A, a cutaneous skin lesion was noted on the upper backs of three of the
family members affected with MTC (14). Further evaluation of
the skin lesions demonstrated them to be consistent with cuta-
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neous lichen amyloidosis. This finding prompted further investigation into the possible association of familial cutaneous
lichen amyloidosis in MEN 2A (Fig I).

Materials and Methods
In 1981, a new family with MEN 2A was discovered following the presentation of the propositus with bilateral pheochromocytoma and MTC. Screening was offered to other family
members who declined any investigation until 1987. At that time
the propositus and several family members agreed to further
screening (Fig 1). During routine physical examination, a scaly,
papular skin lesion on the upper back over the right scapula was
discovered in the propositus and biopsied. Two additionat affected famity members in whom simitar skin lesions were found
underwent a punch biopsy of the affected skin (Fig 2).
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Fig 7—Pedigree of A-kindred demonstrating members effected
with medullary thyroid carcinoma and cutaneous amyloidosis.

The screening procedures for MEN 2A in this famity and the
biopsy procedures are detailed in the originat publication regarding this family (14).

Fig 2—The characteristic raised, thickened, pigmented skin of
left upper back in II-6, mother of propositus.

Results

where her mother's lesion is located. The biopsy results were
consistent with normal skin without evidence of amyloid deposition. Further investigation of the families failed to reveal any
evidence of peripheral neuropathy, cardiomyopathy, or renal
disease usually found in the systemic forms of amyloidosis.
Chromosomal analysis in the propositus and her mother atso has
been been unremarkable (14).

Following treatment of the propositus (III-12), other famity
members agreed to routine screening in 1987. Screening revealed five famity members to be gene carriers for MEN 2A.
Four had documented MTC found in surgically resected specimens. The fifth patient has bilateral thyroid nodules and markedly etevated pentagastrin-stimulated CT levets but has refused
any surgical treatment. Three of thefivepatients with MTC were
noted to have skin lesions on the upper back. The lesion in the
propositus is a targe, scaly, papular skin lesion overlying the left
scapula of the upper back that does not extend across the midline. It was first noted by the patient at the age of 18. The mother
of the propositus (II-6) had a simitar, somewhat larger lesion
over the left scapular region tbat was first noted when she was a
young adult (Fig 2). The third patient (II-5) possessed a simitar,
slightly more erythematous lesion over the right scapular region. Att the patients described the lesions to be associated with
periods of intense praritus. Two additional patients (aged 26 and
32, daughters of patient II-5), both with known MTC, have not
manifested any skin lesions to date.
Punch biopsies of the skin lesions were performed. The microscopic findings of amyloid deposition in the region ofthe
basal layer at the interface of dermis and epidermis are consistent with cutaneous lichen amyloidosis (Fig 3). These observations have been confirmed by positive stains with Congo red and
Crystal violet. Immunohistochemical stains of the amyloid were
positive for keratin and negative for CT. The amyloid from a
focus of MTC of one of the famity members has stained positive
for CT utilizing the same histochemical techniques employed on
the skin lesions. One of the two patients (III-9), who has documented MTC but who has not manifested the characteristic skin
lesions, underwent a random biopsy in the region of the back
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Discussion
Cutaneous lichen amyloidosis is a rare skin abnormality that
usually presents as a scaly, thickened, papular, pigmented area
on the lateral extensor surfaces of the legs and arms or on the
upper back. It is associated with intermittent periods of intense
praritus. Histologically, it is characterized by the intradermal
deposition of amyloid in the papillary dermis. The amyloid is
believed to be derived from keratin, but definitive confirmation
of this has not been made. Cutaneous lichen amyloidosis has
been reported to occur both in hereditary and sporadic forms.
The familial form is transmitted in an autosomal dominant pattern. Less than 75 cases have been reported in the literature
(15-25). Histologic description in the hereditary cases is identical to the skin lesions found in our patients. None of the previous
reports has found amyloidosis in other organ systems, and no
evidence of systemic involvement was found in our patients.
There is no mention of other malignancies such as MTC in the
families described to date.
MEN 2A is an uncommon syndrome of malignant tumors that
follows an autosomal dominant pattem of transmission. The association of MTC with pheochromocytoma and parathyroid hyperplasia is well documented (2,4). The welt described variant
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MEN 2B is associated with a Marfanoid habitus and mucosal
and gastrointestinal ganglioneuromatosis (26-28), Our patients
do not have any features of the MEN 2B syndrome.
Thefindingsof familial cutaneous lichen amyloidosis occurring in a family with MEN 2A, however, prompted us to query
whether there is a link between the two syndromes, A recent report by Nunziata et al (29) describing a family with MEN 2A
who had an almost identical skin lesion to one we report has supported our initiat impression. These authors describe a famity in
which several members with MTC also manifested a pigmented,
raised lesion on the upper back. The affected members experienced periods of intense localized praritus. Affected pafients initially developed severe praritic lesions on the upper back during
childhood at the age of 4 or 5; the lesions have persisted into
adulthood with a residual 5 to 10 cm lesion on the upper back
that does not cross the midline. In this Italian kindred, atl adults
with the skin lesion devetoped MEN 2A. In addition, they have
recentiy demonstrated the presence of amyloid at the interface of
the dermis and epidermis (30). Three children of parents with
MTC have developed a skin lesion on the upper back. Initially,
they atl had normal CT levets. One of these children has since
had elevation of pentagastrin-stimulated CT, and C-cett hyperplasia was confirmed fotlowing thyroidectomy. In our patients,
there have been no cases of the skin lesion occurring in the absence of MTC. While two patients with MTC have not yet manifested the skin lesion, they are still both young and may do so in
the future.
With the exception of the development of the skin lesion at an
earlier age, striking similarities can be noted between our family
and the kindred reported by Nunziata et al (29,30), Both families have MEN 2A, Members of each family have developed a
hereditary praritic skin lesion of the upper back that clinically
and histologically is consistent with familial cutaneous lichen
amyloidosis. In adult family members, the lesion has always occurred in conjuncfion with MTC.
Current understanding of the presence and nature of the
amyloid found in these two syndromes is incomplete. In familial
cutaneous lichen amyloidosis, evidence suggests that the
amyloid is derived from a keratin-like peptide in the skin. This
concept is supported by posirive immunohistochemical staining
forkerarin in our patients (14) and in the Italian family (30).
However, the known genes related to keratin production are located on chromosomes 12 and 17 (31-35). The amyloid present
in MTC appears to be related to the presence of an incomplete or
abnormal CT gene product. The failure to document the presence of CT in skin lesions of our patients by immunohistochemical methods suggests that the amyloid is probably not a
CT gene-related product (36).
Evidence is not available to explain completely the association of hereditary cutaneous lichen amyloidosis and MEN 2A.
The evidence thus far is very suggestive of a contiguous gene
syndrome (37) which is a disorder caused by the individual or
additive effects of a deletion or mutation of contiguous genes on
a single chromosome. While the association of two autosomally
dominant hereditary diseases may have occurred by chance
atone, or alternatively by a series of interrelated biochemical
events regulated by genes on two or more chromosomes, the evidence andralesof probability do not support this theory.
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Fig 3—Histologic appearance of characteristic features of lichen amyloidosis demonstrating the amyloid deposition (arrows) at the epidermal and dermal interface (hematoxylin-eosin
stain, X200).

Conclusions
The association of familial cutaneous lichen amyloidosis in
MEN 2A is a newty defined entity. The rarity of the two syndromes occurring together suggests that it should be categorized
as a variant of MEN 2A and not as a separate syndrome. The
syndrome does not appear to be related to any detectable chromosomal abnormalities. There is a definite but disfinct abnormality of protein production resulting in deposition of a different form of amyloid in the thyroid than in the dermis of the skin.
The association of cutaneous lichen amyloidosis in MEN 2A
may be explained by a contiguous gene syndrome phenomenon.
We recommend that alt patients with MEN 2A should be examined for the presence of cutaneous lichen amyloidosis and alt
patients with hereditary cutaneous lichen amyloidosis should be
screened for MEN 2A. Further investigation into the genetic relationship of the two syndromes is cunently under way.

Addendum
Basal semm CT values in four patients from one famity (16)
with hereditary cutaneous lichen amyloidosis and normal thyroid examinations were measured and found to be normal (highest vatue 22 pg/mL).
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